Male breast cancer: It's time for evidence instead of extrapolation

Onkologie

Volumn 31, Issue 10, 2008, Pages 505-506

  Giordano, Sharon H ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FULVESTRANT; GOSERELIN; LETROZOLE; LEUPRORELIN; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADJUVANT THERAPY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RISK; DRUG ACTIVITY; DRUG EFFICACY; EDITORIAL; EVIDENCE BASED PRACTICE; GENE MUTATION; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; MALE; MALE BREAST; METASTASIS; SEX DIFFERENCE;

BREAST NEOPLASMS, MALE; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HUMANS; MALE; MEDICAL ONCOLOGY;

EID: 53949113832     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000153894     Document Type: Editorial

References (13)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN: Breast carcinoma in men: a population-based study. Cancer 2004;101:51-7.
3. Bauerschmitz GJ, Karan D, Zwiefel K, Bender HG, Mohrmann S: An unusual case of advanced bilateral male breast cancer. Onkologie 2008;31:542-44.
4. Rudlowski C, Friedrichs N, Faridi A, Fuzesi L, Moll R, Bastert G, et al.: Her-2/neu gene amplification and protein expression in primary male breast cancer. Breast Cancer Res Treat 2004;84:215-23.
5. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, et al.: Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104:2359-64.
6. Zabolotny BP, Zalai CV, Meterissian SH: Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer. J Surg Oncol 2005;90:26-30.
7. Italiano A, Largillier R, Marcy PY, Foa C, Ferrero JM, Hartmann MT, et al. Remission complète par letrozole chez un homme traité pour un cancer du sein metastatique. Revue de Médecine Interne 2004;25:323-4.
8. Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol 2002;25:235-7.
9. Mauras N, O'Brien KO, Klein KO, Hayes V. Estrogen suppression in males: metabolic effects. J Clin Endocrinol Metab 2000;85:2370-7
10. Giordano SH, Hortobagyi G: Leuprolide acetate plus aromatase inhibition for male breast cancer. J Clin Oncol 2006;24:e42-e43.
11. Auvinen A, Curtis RE, Ron E: Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst 2002;94:1330-1332.
12. Dong C, Hemminki K: Second primary breast cancer in men. Breast Cancer Res Treat 2001;66:171-172.
13. Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, et al.: BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003;63:342-347.